SciSparc Ltd.
SPRC | NASDAQ
$4.57
+$0.04 (+0.88%)
At close: Sep 22, 2026, 4:00 PM ET
$4.65
+$0.08 (+1.75%)
After-hours:
Sep 22, 2026, 7:57 PM ET
+0.88%
(1D)Rating
Updated: Aug 18, 2026Key Statistics
Market Data
Market Cap $264.32K
1D Range
4.57 4.70
52W Range
2.98 80.10
Valuation (TTM)
PE -
PB 0.06
EV/EBITDA 0.30
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target N/A
Cash Flow
FCF Yield -710.3%
SBC Adj. FCF Yield -710.3%
SBC Impact N/A
Margins
Gross Margin 46.4%
Operating Margin -1022.1%
FCF Margin -217.4%
Growth (CAGR)
Revenue 3Y | 5Y 19.8% |
38.6%
Dil EPS 3Y | 5Y 123.0% |
-9.0%
FCF 3Y | 5Y 37.8% |
4.5%
Returns
ROA -159.8%
ROE -704.6%
ROIC -152.6%
Financial Health
Net Cash
$4.24M
Current Ratio 2.41
Interest Coverage -1.07
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
SciSparc Ltd. is a pharmaceutical company in the clinical development phase, specializing in creating medications derived from cannabinoid molecules. Their therapeutic pipeline encompasses several key...
Sector Healthcare
Industry Biotechnology
Employees 3
IPO Date Aug 29, 2021
Website scisparc.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SPRC